Literature DB >> 1828949

Fc receptors and membrane immunoglobulin.

H Metzger1.   

Abstract

This year there have been three major highlights in this field: genetic sequencing of the principal Fc receptors has been completed; new proteins associated with both Fc gamma receptors and B-cell membrane immunoglobulins have been identified; and there has been an initial analysis of structural-functional relationships in these receptors using genetic engineering.

Mesh：

Substances：

Year:  1991        PMID： 1828949     DOI： 10.1016/0952-7915(91)90074-b

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  5 in total

1.  Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes.

Authors:  H Harashima; K Sakata; K Funato; H Kiwada
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

2.  In vitro activation of a transcription factor by gamma interferon requires a membrane-associated tyrosine kinase and is mimicked by vanadate.

Authors:  K Igarashi; M David; A C Larner; D S Finbloom
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

3.  Interferon gamma rapidly induces in human monocytes a DNA-binding factor that recognizes the gamma response region within the promoter of the gene for the high-affinity Fc gamma receptor.

Authors:  K C Wilson; D S Finbloom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

4.  Tyrosine phosphorylation of phospholipase C-gamma 1 induced by cross-linking of the high-affinity or low-affinity Fc receptor for IgG in U937 cells.

Authors:  F Liao; H S Shin; S G Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

5.  Modulation of the Fc gamma RII and Fc gamma RIII induced by GM-CSF, IFN-gamma and IL-4 on murine eosinophils.

Authors:  B de Andrés; B Cárdaba; V del Pozo; E Martín-Orozco; S Gallardo; P Tramón; P Palomino; C Lahoz
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.